
A Georgia woman says a dentist prescribed an antibiotic that triggered frightening symptoms years after a documented drug reaction left her in a coma and scarred for life.
Story Snapshot
- Court and news records show a 2014 lamotrigine reaction led to a Stevens-Johnson syndrome diagnosis and a medically induced coma.
- A 2025 dental visit ended with an amoxicillin prescription and rapid facial swelling and membrane irritation after six doses, according to the patient’s account.
- Expert testimony in a Georgia case linked the 2014 reaction to incorrect lamotrigine titration and called it avoidable.
- Researchers report antiepileptic drugs account for about 23% of Stevens-Johnson syndrome and toxic epidermal necrolysis cases.
Documented 2014 Drug Reaction and Hospitalization
Georgia records and news reports document that in 2014, Khaliah Shaw developed a severe blistering and peeling illness after starting lamotrigine. Doctors diagnosed Stevens-Johnson syndrome. She spent more than a month in a medically induced coma and suffered lasting scarring and disability. A Georgia Court of Appeals summary describes expert testimony that incorrect dose escalation of lamotrigine, also sold as Lamictal, caused the life-threatening rash to a reasonable medical probability. Those records frame the 2014 event as a confirmed, catastrophic drug reaction.
Reporting from Houston and Tampa outlets the same year also tied her condition to lamotrigine, reinforcing that the first crisis was linked to the medication and recognized as Stevens-Johnson syndrome by treating teams. The court summary notes that the expert characterized the reaction as avoidable with proper titration. These consistent references across legal and media documents establish the severity and medical basis of the 2014 episode without meaningful dispute in the public record.
Reported 2025 Dental Antibiotic and Rapid Symptoms
In July 2025, Shaw visited a dentist for an infected tooth. She says she warned the provider about her 2014 drug reaction and asked for a different option. The dentist labeled the history as an allergy and prescribed amoxicillin, a common antibiotic. Shaw reports that after six doses over two days, she developed facial swelling and irritation of the eyes and mouth membranes. The account describes symptoms beginning quickly after the antibiotic started.
The available 2025 reporting relies on Shaw’s description and does not present a hospital diagnosis or specialist note confirming Stevens-Johnson syndrome for that episode. The narrative, however, lays out a clear sequence: infection, prescription, multiple doses, and mucosal and facial symptoms that prompted concern. That timeline matters because earlier severe reactions can raise vigilance for later drug-related problems, even when a second reaction is not clinically classified in public records.
Medical Context for Severe Skin Reactions
Stevens-Johnson syndrome and toxic epidermal necrolysis are rare, often drug-induced conditions that can become life-threatening. A meta-analysis found about 23% of these cases were linked to antiepileptic drugs, with lamotrigine a known trigger within that class. Separate research estimates show a very small share of people taking lamotrigine develop Stevens-Johnson syndrome or toxic epidermal necrolysis, while milder rashes are more common. Experts have warned that fast dose increases of lamotrigine raise the risk of severe skin reactions.
These data place Shaw’s 2014 experience in a recognized risk zone: an antiepileptic drug, a titration dispute, and a documented severe outcome. They also explain public interest. When common medicines can, on rare occasions, cause catastrophic harm, patients want clear warnings and careful follow-up. Families want prescribers, dentists, and pharmacists to share information and confirm allergy lists before writing or filling new orders. Systems that miss this step can expose patients to preventable danger.
Why This Story Hits a Nerve on Left and Right
Americans across the political spectrum worry that large systems put speed and routine over safety. Patients expect careful reviews of life-threatening drug histories at every visit, whether in a hospital, a clinic, or a dental office. When that fails, people see an impersonal machine that forgets the human being at the center. Shaw’s 2014 case shows how a dosing mistake can spiral into a medical disaster. Her 2025 account underscores how fragile trust feels when records and reality do not align.
Clear steps can help. Patients should carry a written list of severe reactions and show it before any new prescription. Dentists and doctors should confirm those histories, document them, and choose safe alternatives when possible. Pharmacists should cross-check and counsel on warning signs. Policymakers can fund better health information exchange so critical alerts follow the patient. These are basic safeguards that do not require partisanship—only respect for people’s lives and the duty to do no harm.
Sources:
mirror.co.uk, law.justia.com, khou.com, fox13news.com, the-independent.com, allure.com, pmc.ncbi.nlm.nih.gov
© newsworthy.news 2026. All rights reserved.













